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The Millennium Development 
Goals
One of the most important and 
visionary global actions of recent years 
was the September 2000 commitment 
by 189 governments worldwide to 
“[make] the right to development a 
reality for everyone and to [free] the 
entire human race from want” [1]. 
The movement to achieve sustainable 
reductions across all dimensions 
of extreme poverty has reached an 
unprecedented level, with efforts 
primarily focused on and measured 
against the Millennium Development 
Goals (MDGs; see http:⁄⁄www.un.org/
millenniumgoals/goals.html) [2].
To date, progress toward achieving 
these goals has been mixed: in some 
regions such as East Asia, most 
countries have made important gains 
across the board and are thus “on 
track,” or better, for reaching many 
MDG targets. But in other regions, 
most notably in sub-Saharan Africa, 
a large number of countries are far 
behind and appear unlikely to reach, 
or even come close to reaching, their 
goals for 2015 [2]. 
The reasons for this are complex 
and often interlinked, but one stands 
out as a major overarching threat to 
development: HIV/AIDS, which kills 
more people than any other infectious 
disease and is the fourth-leading 
cause of death worldwide [3]. The 
severe health impacts of AIDS are well 
documented. But AIDS also affects 
countries’ fundamental economic and 
social development performance, and 
exerts detrimental effects on many 
of the other MDGs. AIDS will make 
it difﬁ  cult if not impossible for many 
countries to achieve their MDG targets 
[4].
This Policy Forum reviews the 
literature on the impact of AIDS 
on selected MDGs, and explores 
the links between ﬁ  ghting AIDS 
and improving other development 
outcomes. It also considers the 
implications for developing country 
and donor investment strategies, 
arguing that expanded investment 
in HIV prevention—especially in 
new prevention tools including AIDS 
vaccines—is essential for attaining and 
upholding the MDGs. 
Methodology
We examine how HIV/AIDS impedes 
progress toward several of the MDGs, 
beyond the direct target dedicated 
to reducing the HIV epidemic itself. 
Based on availability of data, we focus 
on the following MDGs: (1) eradicating 
extreme poverty and hunger; (2) 
achieving universal primary education; 
(3) reducing child mortality; (4) 
improving maternal health; and (5) 
combating malaria and tuberculosis 
(TB).
Our analysis draws on primary 
sources published over the past ﬁ  ve 
years (2000–2005). The literature 
search, conducted between January 
and November 2005, relied on general 
searches of the PubMed database, in 
addition to consultations with experts 
from the respective ﬁ  elds to identify 
key representative peer-reviewed 
articles.
We give a snapshot of the effects 
of HIV/AIDS on each of the MDGs. 
The approach does not attempt to 
capture all the interactions among 
these development outcome measures. 
In addition, the paper is unidirectional 
in its analysis of the impact of AIDS: it 
does not try to explain, for instance, 
how poverty may increase transmission 
of and susceptibility to HIV. These 
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Figure 1. Orphans—Statistics and 
Predictions 
Data derived from [3,27,55].
doi:10.1371/journal.pmed.0030455.g002
Figure 2. Underweight Prevalence among 
Children Under Four, Lesotho 
Figure derived from [18].PLoS Medicine  |  www.plosmedicine.org 1993
relationships have been explored 
elsewhere [5–9].
HIV/AIDS Increases Poverty
Nations suffer at the macroeconomic 
level. Various studies, using a range 
of modeling techniques, argue that 
AIDS lowers national gross domestic 
product (GDP) growth by up to 1.5% 
annually [10]. An analysis across 80 
developing countries predicts that in a 
“typical” African country with 20% HIV 
prevalence, the rate of GDP growth 
would be 2.6% lower each year than 
it would have been in the absence of 
AIDS. At the end of a 20-year period, 
GDP would be 67% lower than it would 
have been in the absence of AIDS at 
the end of a 20-year period [11].
Households face revenue losses and 
heavy costs. Because of high medical 
costs, as well as other expenses, of HIV-
related illness and death, and because 
AIDS often kills working-age adults, the 
epidemic has a signiﬁ  cant impact at the 
household level. Studies from Thailand 
and South Africa show that poverty is 
higher among households affected by 
HIV and AIDS than among unaffected 
families [12,13]. 
A recent analysis of household data 
from Botswana, drawing on income and 
expenditure surveys, suggests that HIV/
AIDS can be expected to lower average 
income per capita by 10% over the next 
ten years. It also shows that the income 
loss is twice as large among the poorest 
households as it is for the overall 
population, suggesting that extreme 
poverty will become entrenched because 
of HIV/AIDS [14]. A similar correlation 
between AIDS deaths and declining 
household wealth was found in rural 
Kenyan households [15].
These effects will escalate over time. 
The long-term negative impact of 
AIDS can be expected to accelerate. 
Classic GDP growth models may fail 
to capture the negative long-term 
intergenerational effects of HIV/AIDS. 
One analysis that models the impact 
of HIV/AIDS over three generations 
shows how AIDS could produce a 
progressive collapse of the economy. 
Declining family income forces parents 
to choose immediate consumption 
(e.g., food and medical expenditures) 
over long-term investments in the 
next generation’s human capital (e.g., 
school fees). As a result, children of 
parents who die of AIDS have less 
human capital to pass on to their own 
children [16]. 
The steadily increasing number 
of orphans in developing countries 
indicates how severe this problem 
could become (Figure 1). In South 
Africa, only 29% of children are 
expected to be living with both parents 
at the end of the current decade. 
Nearly one-ﬁ  fth of children will have 
lost both parents [16]. 
HIV/AIDS Worsens the Nutritional 
Status of Children
Worldwide, 53% of annual deaths 
among children under ﬁ  ve are 
associated with malnutrition [3]. 
In areas with a high prevalence of 
HIV, progress in reducing childhood 
malnutrition has been mixed, and 
there is growing evidence of an 
important link between child nutrition, 
food security, and HIV/AIDS. In one 
study of 44 sub-Saharan countries, HIV 
prevalence was signiﬁ  cantly negatively 
correlated with increasing calorie and 
protein consumption [8]. 
Some data suggest that HIV/AIDS 
contributes to food crises in areas 
where HIV prevalence is high [17]. 
For example, a study that examines 
the impact of the 2002 drought in 
southern Africa ﬁ  nds that in six 
affected countries, child nutrition 
rapidly deteriorated in the presence of 
high HIV prevalence. The proportion 
of underweight children rose from 5% 
to 20% in Maputo (1997–2002), with 
similar increases in other sub-Saharan 
regions. Changes were much smaller 
during non-drought periods and in 
areas with lower HIV prevalence [18].
AIDS also affects child nutrition 
through parental mortality. Orphaned 
children are less likely to receive 
adequate nutrition. For example, in the 
Kagera region of Tanzania, maternal 
orphans lost on average one standard 
deviation in height, while paternal 
orphans’ height declined one-third of 
a standard deviation [19]. A study from 
Kenya shows that weight-for-height 
scores in 2000 were almost 0.3 standard 
deviations lower for orphans [20]. In 
Lesotho, almost 40% of children under 
four who had lost both parents were 
underweight, compared with 16% of 
non-orphans (Figure 2) [18].
AIDS Compromises Efforts to 
Reach Universal Primary Education
The AIDS epidemic can negatively 
affect both the demand for and supply 
of education. AIDS may prevent 
children from enrolling in school, or 
doi:10.1371/journal.pmed.0030455.g003
Figure 3. Educator Mortality Rates by Age and Gender, South Africa, 1997/1998 and 
2003/2004
Figure derived from [26].
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cause them to be taken out of school. 
It can also cause absenteeism and 
mortality of teachers and staff, lowering 
educational quality and preventing 
children from obtaining schooling.
AIDS reduces the demand for 
schooling. Children in areas affected by 
AIDS may drop out of school because 
they or their families cannot afford fees 
or supplies, or because their families 
increasingly rely on them to contribute 
economically to the household or to 
care for ill family members. In a study 
in the Kagera region of Tanzania, 
young children (seven to ten years of 
age) who lost their mothers had their 
schooling delayed, though enrollment 
of older children (11–14 years of age) 
was not affected [21]. A survey in 
Indonesia found that 14% of children 
who had lost a parent dropped out 
of school between ages six and ten, 
whereas only 7% of non-bereaved 
children did [22]. 
Another study, however, suggests 
that orphan status may not have 
a signiﬁ  cant bearing on school 
enrollment [23]. The survey found 
larger differentials in enrollment 
among the 29 countries studied than 
between orphans and non-orphans. 
The authors qualify their ﬁ  ndings by 
pointing out that schooling may be 
most affected before a sick parent dies 
(when time and household resources 
are devoted to caring for the ill adult), 
so the impact of parental death on 
enrollment may have been greater than 
the study found.
The theory that orphans experience 
disadvantages when they are not closely 
related to the head of the household 
could explain the discrepancy in these 
results. A review of 19 Demographic 
and Health Survey studies in ten 
African countries found a correlation 
between enrollment of orphans and 
the degree to which they were related 
to their guardians [24]. 
AIDS also hampers countries’ 
abilities to supply education. In many 
countries, educational administrators 
face substantial challenges in 
replacing teachers who die. Even 
when replacement teachers are 
readily available, the death of a 
teacher imposes substantial costs (for 
temporary and permanent teacher 
replacement, as well as for training) on 
education systems [25].
A comprehensive study of public 
schools in South Africa provides an 
overview of the attrition of educators 
and of mortality trends (Figure 3). 
Data from 1997 to 2004 show that many 
teachers were infected with HIV, and 
the total number of in-service deaths 
(from all causes) grew by about 30% 
during this period. The proportion of 
attrition of educators due to deaths 
increased from 7.0% to 17.7%, and the 
proportion of contract terminations 
attributed to medical reasons grew 
from 4.5% to 8.7% [26]. 
AIDS Has a Negative Impact on 
Child Mortality
Worldwide, approximately 10.6 million 
children under ﬁ  ve died in 2003. More 
than 40% of these deaths occurred in 
Africa [27]. Many countries in Africa 
with a high prevalence of HIV are off 
track in achieving the child mortality 
MDG (Figure 4). In ﬁ  ve countries that 
currently have adult HIV prevalence 
rates above 10% (Zambia, South Africa, 
Zimbabwe, Botswana, and Swaziland), 
under-ﬁ  ve mortality not only failed 
to decline between 1990 and 2003, it 
actually increased during that period 
[28].
Though AIDS contributes only 
modestly to global child mortality 
[29,30], the negative effects of HIV/
AIDS are signiﬁ  cant in high-prevalence 
areas. For instance, one analysis 
estimates that by 2015, up to 90% of 
under-ﬁ  ve deaths in Botswana will be 
directly or indirectly caused by HIV/
AIDS [31]. Where the prevalence of 
HIV continues to increase in young 
women—as in many countries in sub-
Saharan Africa—this effect will grow.
AIDS increases child mortality 
directly and indirectly. The vast 
majority of children living with HIV 
acquired the virus through perinatal 
transmission. And 60% of children 
with HIV die before their ﬁ  fth birthday 
[32]. In this manner, AIDS directly 
accounted for about 570,000 child 
deaths in 2005 [33].
Child mortality can be attributed to 
AIDS even when HIV is not the direct 
cause of death, since children are made 
vulnerable to a range of economic 
and social “injuries” caused by their 
parents’ illness and death. Maternal 
HIV status is a strong predictor of child 
survival, regardless of a child’s HIV 
status [34]. Several studies have shown 
that children born to mothers with HIV 
are approximately three times more 
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Figure 4. Change in Under-Five Mortality Rate in Select Countries with High HIV Prevalence, 
1990–2003 
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likely to die than children born to 
mothers not infected with HIV (Figure 
5) [32,34,35]. 
The effect of AIDS on child mortality 
is increasing. An analysis of HIV-related 
risk of death before age ﬁ  ve in 42 sub-
Saharan African countries estimates 
that in 1999, HIV accounted for 7.7% 
of under-ﬁ  ve mortality, up from 2% in 
1990 [36]. Another study estimates that 
in 2002, nearly 10% of all under-ﬁ  ve 
deaths in sub-Saharan Africa could be 
attributed to HIV/AIDS [35].
When the analysis breaks down HIV-
related proportional attributable child 
mortality for individual countries for 
1999, countries with high prevalence 
show the effect of HIV even more 
strongly (Figure 6). For instance, in 
Botswana, Zimbabwe, and Namibia, 
the percentage of under-ﬁ  ve deaths 
attributable to HIV/AIDS is estimated 
at 42.4%, 35.1%, and 26.8%, 
respectively [36]. 
HIV/AIDS Worsens Maternal Health
Each year, more than 500,000 women 
die from pregnancy and childbirth-
related complications, and at least 
10 million suffer serious injuries or 
disabilities. More than 80% of these 
deaths occur in sub-Saharan Africa and 
South Asia [37]. 
HIV/AIDS can signiﬁ  cantly increase 
maternal mortality ratios. Evidence 
suggests that suppressed immunity 
causes higher risks of prenatal and 
childbirth complications including 
miscarriage, anemia, postpartum 
hemorrhage, and puerperal sepsis, in 
addition to increasing the chances of 
dying from indirect causes during and 
after pregnancy, such as malaria or 
pneumonia [38].
Thus, maternal mortality ratios for 
women who are HIV positive can be 
substantially higher than for those who 
do not have HIV. For example, in Malawi 
and Zimbabwe, surveys suggest that the 
risk of pregnancy-related death is eight 
to nine times higher in women who are 
HIV positive. When HIV prevalence 
rates among pregnant women increased 
10-fold between 1991 and 2001 in these 
countries, overall maternal mortality 
increased 1.9 and 2.5 times, respectively, 
likely as a result of this heightened risk 
[39]. A similar study in Rakai, Uganda, 
found the rate of maternal deaths of 
women who are HIV positive to be more 
than three times the rate of women who 
do not have HIV [40]. 
A study in South Africa shows that 
the proportion of maternal deaths 
due to indirect infections (including 
HIV) increased from 23% to 31% 
over the period 1998–2001, making 
these infections the most signiﬁ  cant 
causes of maternal mortality [41]. In 
high-prevalence areas, this effect can 
substantially skew the population-wide 
maternal mortality ratio. 
HIV Exacerbates the Effects 
of Malaria
Recent studies suggest that HIV 
has signiﬁ  cant effects on the 
incidence of malaria. HIV-induced 
immunodeﬁ  ciency may decrease the 
immune response against malarial 
infection [42], and indeed, the risk 
of parasitemia and illness has been 
inversely correlated to CD4 cell counts 
[43]. 
HIV co-infection in areas where 
malaria transmission is intense 
primarily increases the risk of 
parasitemia and clinical malaria in 
adults [43], and clinical malarial fever 
in children (although the evidence 
supporting a link between HIV 
infection and clinical malarial fever is 
stronger in adults than in children) 
[44]. In unstable malaria regions, in 
which transmission is intermittent and 
unpredictable, high HIV prevalence 
results in signiﬁ  cantly higher malaria 
morbidity and mortality [45].
Clinical studies have also shown that 
HIV affects the incidence of malaria 
and disease progression in pregnant 
women. Increased rates of peripheral 
and placental parasitemia, higher 
doi:10.1371/journal.pmed.0030455.g005
Figure 5. Cumulative Proportion of Children Dying by Mother’s HIV Status and Survival in 
Uganda, 1989–2000
Figure derived from [34].
doi:10.1371/journal.pmed.0030455.g006
Figure 6. HIV-Related Population 
Proportional Attributable Risk of Dying 
before Age Five, Sub-Saharan Africa, 1999
Figure derived from [36].
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parasite densities, and higher incidence 
of malaria, anemia, febrile illnesses, 
and adverse birth outcomes have been 
documented with HIV and malaria co-
infection [46]. 
Infection with HIV also affects 
the treatment and prophylaxis of 
malaria. Antimalarial therapy works 
best in individuals with some previous 
immunity to malaria, so the immune 
suppression associated with HIV 
infection may decrease the response to 
antimalarial therapy [47]. 
HIV/AIDS Undermines Global 
Efforts to Control TB
The epidemics of HIV and TB are 
closely intertwined. Of the 40 million 
individuals who are HIV positive 
worldwide, it is estimated that nearly 
one-third are also infected with 
TB [48]. Because of HIV-related 
immunosuppression, individuals with 
HIV who carry the TB bacillus are more 
susceptible to active TB than carriers 
who are HIV negative. 
The risk of acquiring TB doubles 
soon after HIV infection, and increases 
during subsequent years [49,50]. One 
study estimates that 9% of the 8.3 
million new adult TB cases worldwide 
in 2000 were directly attributable to 
HIV [48]. In addition, HIV infection 
makes it harder to treat active TB 
successfully [49]. 
Thus TB rates are actually increasing 
in high-HIV-prevalence areas of sub-
Saharan Africa (Figure 7), and the 
spread of HIV in sub-Saharan Africa is 
primarily responsible for driving the 
number of active TB cases upward by 
6% each year [48]. A recent review 
on progress toward reaching the 
MDGs argues that the AIDS epidemic 
represents the greatest emerging threat 
to TB control [51]. 
Conclusion: Sustainable Strategies 
to Stop the AIDS Epidemic
There has been considerable progress 
on the global response to AIDS, with 
a concomitant increase in resources 
for the currently available range of 
interventions. Yet AIDS continues to 
ravage large parts of the world today: 
nearly 40 million people were living 
with the disease as of the end of year 
2005, and more than 4 million were 
newly infected last year [52].
Failure to halt and reverse the AIDS 
epidemic will continue to jeopardize 
progress toward achieving a wide range 
of the MDGs. It will not only thwart 
the direct objective—stopping HIV 
infection and AIDS-related illness 
itself—but it will also undermine 
progress in areas as diverse as lowering 
poverty rates, ensuring that all children 
complete primary education, reducing 
child death rates, improving maternal 
health, and ﬁ  ghting the global malaria 
and TB epidemics. 
From now until the 2015 MDG target 
date, it is essential that the delivery of 
existing interventions for prevention, 
treatment, and mitigation of the 
social effects of HIV be dramatically 
increased. The recent release of a 
prevention strategy from the Joint 
United Nations Programme on HIV/
AIDS—which advocates increased 
funding, intersectoral efforts, and 
strengthening of institutional capacity—
is a welcome development [53].
Yet more must be done to link HIV 
prevention to other development 
programs to ensure that they 
adequately address the effects of 
AIDS that extend beyond the domain 
of health to reduce the pandemic’s 
negative effects on progress toward 
other social and economic goals. HIV/
AIDS programs should be at the center 
of overall development strategies. 
At the same time, it is essential to 
invest in the development of the new 
and better technologies needed for 
more-effective prevention, diagnosis, 
and treatment of HIV/AIDS. In 
addition to expanding treatment 
programs to prolong the lives of those 
living with HIV, the best chance of 
ultimately controlling the epidemic 
will come from new preventive 
technologies—notably vaccines and 
microbicides. Models of the impact of 
even partially effective vaccines with 
modest uptake estimate that 30–70 
million individuals could be protected 
from HIV over 15 years of use [54].
Part of the commitment to long-
term prosperity for the world’s poorest 
countries must therefore include 
investing in these HIV prevention tools 
for the future. Governments, donors, 
and civil society need to increase 
funds for HIV prevention research 
and product development, and build 
political support, especially for the 
deeper involvement of developing 
countries. The international 
community must also promote 
expanded industry participation, a 
more-coordinated scientiﬁ  c effort, and 
policies and programs that accelerate 
the testing of novel vaccines and 
microbicides. Such actions are needed 
today and must be maintained in the 
future, including after 2015. The MDG 
targets can help assess progress and 
motivate political support, yet the goal 
of global development should be not 
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Figure 7. Tuberculosis Case Notiﬁ  cation Rates, 1980–2003 
Figure derived from [56].PLoS Medicine  |  www.plosmedicine.org 1997
just for 2015 but also for the entire 
21st century.  
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